A Home-based Breathing Training on Menopausal Symptoms

NCT ID: NCT03082040

Last Updated: 2020-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

57 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-26

Study Completion Date

2017-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, triple-blinded and randomized controlled trial examining the effects of a home-based breathing training assisted with biofeedback on menopausal symptoms and autonomic functions among community menopausal women. We also examines whether the changes in autonomic functions would be mediators between slow breathing and menopausal symptoms. This study will include menopausal women, aged from 45 to 64, who experienced menopausal symptoms. Participants will be randomly assigned to either an intervention group (n = 80) or a waiting-list control group (n = 80). The intervention group will undergo the home-based breathing training 20 minutes twice daily and participants in the control condition will participate the same breathing training after a four-week waiting list period. The primary outcome measures are menopausal symptoms measured by symptom diaries of menopausal symptoms and the Greene Climacteric Scale (GCS). Secondary outcome measures are autonomic functions expressed by blood pressure (BP), heart rate (HR) and heart rate variability (HRV). Measurements will be taken at baseline, week 4, and week 8.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ditto

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menopause Menopause Related Conditions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention group

The intervention group will undergo a home-based breathing training 20 minutes twice daily for four weeks

Group Type EXPERIMENTAL

home-based breathing training

Intervention Type BEHAVIORAL

The intervention group will undergo a home-based breathing training 20 minutes twice daily for four weeks. Participants in the control condition will participate the same breathing training after a four-week waiting list period.

waiting-list control group

Participants in the control condition will conduct the same breathing training as the intervention group after a four-week waiting list period

Group Type OTHER

home-based breathing training

Intervention Type BEHAVIORAL

The intervention group will undergo a home-based breathing training 20 minutes twice daily for four weeks. Participants in the control condition will participate the same breathing training after a four-week waiting list period.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

home-based breathing training

The intervention group will undergo a home-based breathing training 20 minutes twice daily for four weeks. Participants in the control condition will participate the same breathing training after a four-week waiting list period.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged from 45 to 64, reporting cessation of menstrual cycles with natural causes ≧ 12 consecutive months
* the Greene Climacteric Scale (GCS) Chinese version scores ≧ 1

Exclusion Criteria

* clinically diagnosed with history of cardiac arrhythmia, coronary heart disease, heart failure, kidney disease, hypertension, chronic low blood pressure, diabetic neuropathy, psychosis or mental deficiency
* received hormone replacement therapy prescribed by gynecological physicians
* took cardiac medications which may affect the autonomic functions, ex., β-blockers, etc.
Minimum Eligible Age

45 Years

Maximum Eligible Age

64 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Science and Technology, Taiwan

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yuh-Kae Shyu

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yuh-Kae Shyu, PhD

Role: PRINCIPAL_INVESTIGATOR

Fu Jen Catholic University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fu Jen Catholic University

New Taipei City, Xinzhuang Dist, Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MOST105-2314-B-030-006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acupuncture for Relieving Perimenopausal Symptoms
NCT01933204 COMPLETED PHASE2/PHASE3
Qing'E Formula Therapy on Menopausal Symptoms
NCT01805765 COMPLETED PHASE2/PHASE3
Does Menopause Matter?
NCT00097994 COMPLETED